Author:
Wang Shirui,Luo Dan,Pu Chunlan,Ma Xinyu,Zhang Hongjia,Feng Zhanzhan,Deng Rui,Yu Su,Liu Yuanyuan,Huang Qing,Li Rui
Funder
National Natural Science Foundation of China
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference47 articles.
1. Proteolysis targeting chimeras (PROTACs): a perspective on integral membrane protein degradation;Ruffilli;ACS Pharmacol. Transl. Sci.,2022
2. PROTACting the kinome with covalent warheads;Chatterjee;Drug Discov. Today,2022
3. PROTAC therapy as a new targeted therapy for lung cancer;Li;Mol. Ther.,2022
4. Blocking non-enzymatic functions by PROTAC-mediated targeted protein degradation;Sun;J. Med. Chem.,2022
5. A bibliometric analysis of PROTAC from 2001 to 2021;Li;Eur. J. Med. Chem.,2022
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献